GAMIDA CELL LTD (GMDA) Stock Overview
NASDAQ:GMDA - IL0011552663 - Common Stock
GMDA Key Statistics, Chart & Performance
The current stock price of GMDA is 0.0327 USD. In the past month the price decreased by -90.3%. In the past year, price decreased by -95.57%.
GMDA Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 19.68 | 368.08B | ||
| AMGN | AMGEN INC | 13.28 | 155.90B | ||
| GILD | GILEAD SCIENCES INC | 14.83 | 142.38B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 22.86 | 99.27B | ||
| REGN | REGENERON PHARMACEUTICALS | 12.88 | 62.29B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 59.14B | ||
| ARGX | ARGENX SE - ADR | 76.39 | 43.34B | ||
| ONC | BEONE MEDICINES LTD-ADR | 6.24 | 36.72B | ||
| INSM | INSMED INC | N/A | 27.94B | ||
| BNTX | BIONTECH SE-ADR | N/A | 25.19B | ||
| NTRA | NATERA INC | N/A | 22.74B | ||
| BIIB | BIOGEN INC | 8.54 | 20.04B |
Related stock screener links
About GMDA
Company Profile
Gamida Cell Ltd. engages in the development of cell therapies to cure blood cancer and rare serious hematologic diseases. The firm develops cell therapies that are designed to cure cancer and rare, serious hematologic diseases. The firm is leveraging its nicotinamide (NAM)-based cell expansion technology toto expand multiple cell types including stem cells and natural killer (NK) cells while maintaining their original phenotype and potency. The following are the Company's clinical pipeline products: Omidubicel dedicated to hematologic malignancies and severe aplastic anemia; GDA-201 dedicated for treatment of non-Hodgkin Lymphoma; GDA-301, GDA-401, GDA-501 dedicated to treatment of solid tumors, GDA-601 dedicated to multiple myeloma.
Company Info
GAMIDA CELL LTD
PO Box 34670
JERUSALEM 95484 IL
CEO: Julian Adams
Employees: 143
Phone: 97226595666
GAMIDA CELL LTD / GMDA FAQ
What is the stock price of GAMIDA CELL LTD today?
The current stock price of GMDA is 0.0327 USD. The price decreased by -18.25% in the last trading session.
What is the ticker symbol for GAMIDA CELL LTD stock?
The exchange symbol of GAMIDA CELL LTD is GMDA and it is listed on the Nasdaq exchange.
On which exchange is GMDA stock listed?
GMDA stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for GAMIDA CELL LTD stock?
10 analysts have analysed GMDA and the average price target is 4.42 USD. This implies a price increase of 13416.73% is expected in the next year compared to the current price of 0.0327. Check the GAMIDA CELL LTD stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is GAMIDA CELL LTD worth?
GAMIDA CELL LTD (GMDA) has a market capitalization of 4.34M USD. This makes GMDA a Nano Cap stock.
How many employees does GAMIDA CELL LTD have?
GAMIDA CELL LTD (GMDA) currently has 143 employees.
Is GAMIDA CELL LTD (GMDA) expected to grow?
The Revenue of GAMIDA CELL LTD (GMDA) is expected to grow by 808.75% in the next year. Check the estimates tab for more information on the GMDA EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy GAMIDA CELL LTD (GMDA) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of GMDA, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of GMDA, evaluating the profitability, health, valuation and growth aspects
- GAMIDA CELL LTD (GMDA) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- GAMIDA CELL LTD (GMDA) Sales and EPS estimates to see what analysts future expectations are.
- GAMIDA CELL LTD (GMDA) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- GAMIDA CELL LTD (GMDA) Insider and Institutional Ownership to learn about the owners and their transactions.
- GAMIDA CELL LTD (GMDA) Stock Chart to make your own analysis
- GAMIDA CELL LTD (GMDA) Latest news and press-releases to stay up to date.
Does GAMIDA CELL LTD (GMDA) stock pay dividends?
GMDA does not pay a dividend.
When does GAMIDA CELL LTD (GMDA) report earnings?
GAMIDA CELL LTD (GMDA) will report earnings on 2024-05-07, after the market close.
What is the Price/Earnings (PE) ratio of GAMIDA CELL LTD (GMDA)?
GAMIDA CELL LTD (GMDA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.63).
GMDA Technical Analysis
GMDA Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to GMDA. GMDA has a bad profitability rating. Also its financial health evaluation is rather negative.
GMDA Financial Highlights
Over the last trailing twelve months GMDA reported a non-GAAP Earnings per Share(EPS) of -0.63. The EPS increased by 49.19% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -61.65% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
GMDA Forecast & Estimates
10 analysts have analysed GMDA and the average price target is 4.42 USD. This implies a price increase of 13416.73% is expected in the next year compared to the current price of 0.0327.
For the next year, analysts expect an EPS growth of 9.37% and a revenue growth 808.75% for GMDA